Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, Suraksha Diagnostic has informed that in terms of Company's Code of Conduct for regulating, monitoring and reporting of trading by insiders, the trading window for dealing in securities of the Company will remain closed for all designated person and their immediate relatives from Wednesday, 01 January 2025 till 48 hours after the declaration of unaudited financial results (both standalone and consolidated) of the Company for the quarter ended 31 December 2024. The same is being informed to the designated person and connected person in accordance with the Company’s Code of Conduct for Prohibition of Insider Trading. Further, the date of meeting of the Board of Directors of the Company to consider and approve the unaudited financial results (both standalone and consolidated) of the Company for the said period shall be informed in due course.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8094.85 |
| Max Healthcare Inst | 1012.35 |
| Narayana Hrudayalay | 1819.75 |
| Aster DM Healthcare | 742.40 |
| Global Health | 1200.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: